FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used for correction of pathological changes of lymphatic bed in crush syndrome in experiment. For this purpose perftoran is introduced intravenously in experimental animals in dose of 2 mg/kg of body weight and lymphotropic 0.2–0.4 ml 1 time a day for 3 days.
EFFECT: invention provides correcting pathomorphological changes induced by postcompression endotoxicosis due to angioprotective and detoxification action of perftoran.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF WAVY OPEN FASCIOTOMY AT CRUSH SYNDROME | 2007 |
|
RU2350283C1 |
| METHOD FOR TREATING PROLONGED COMPRESSION SYNDROME CASES UNDER EXPERIMENTAL CONDITIONS | 2005 |
|
RU2299734C1 |
| METHOD FOR TREATING HEAVY COMPRESSION INJURY OF SOFT TISSUES | 2004 |
|
RU2289395C2 |
| METHOD FOR OPTIMIZING FUNCTIONS OF LYMPH NODES BY METHOD OF CLOSED NON-INVASIVE LAVAGE OF LYMPHATIC SYSTEM | 2021 |
|
RU2777208C1 |
| METHOD FOR TREATING ISCHEMIC FORM OF DIABETIC FOOT SYNDROME ALONG WITH DISTAL TYPE OF LESION IN ARTERIES OF INFERIOR LIMBS | 2005 |
|
RU2308945C2 |
| METHOD OF INDIRECT ENDOLYMPHIC ANTIBIOTIC THERAPY OF PATIENTS ILL WITH SEPSIS | 1997 |
|
RU2134593C1 |
| METHOD FOR TREATING WOUNDS | 2003 |
|
RU2237473C1 |
| METHOD OF ESTIMATION OF FUNCTIONAL STATE OF LYMPHATIC SYSTEM | 2006 |
|
RU2334464C2 |
| METHOD OF TREATING CATARACT IN PATIENTS WITH PSEUDOEXFOLIATION SYNDROME | 2013 |
|
RU2515550C1 |
| METHOD FOR TREATING WOUNDS | 2005 |
|
RU2314756C2 |
